Jorge Velarde

Jorge joined Singular Genomics and established the commercial organization, serving as Senior Vice President of Corporate Development and Strategy. Jorge has helped build several highly successful organizations, from startup to public company, in the fields of genomics and clinical diagnostics. Jorge was an early business lead at Illumina as Vice President, leading corporate and business development along with alliance management functions for more than 10 years. He was one of the early employees at Gen-Probe and played a key business development role in the commercialization of DNA probe diagnostics for blood banks and clinical laboratories globally. Jorge was the scientific co-founder of Chugai Biopharmaceuticals and the co-inventor of an HIV drug that went into human clinical trials. Jorge most recently served as CEO of BaseHealth and currently serves on the board of Kura Biotech, a leading toxicology and diagnostics company.

Jorge received an MBA from the Paul Merage School of Business at the University of California, Irvine and a BS in Molecular Biology from Loyola University.